286 related articles for article (PubMed ID: 32765421)
1. Laryngeal Neuroendocrine Tumor With Elevated Serum Calcitonin: A Diagnostic and Therapeutic Challenge. Case Report and Review of Literature.
Feola T; Puliani G; Sesti F; Modica R; Biffoni M; Di Gioia C; Carletti R; Anastasi E; Di Vito V; Centello R; Lenzi A; Isidori AM; Faggiano A; Giannetta E
Front Endocrinol (Lausanne); 2020; 11():397. PubMed ID: 32765421
[No Abstract] [Full Text] [Related]
2. Poorly differentiated laryngeal neuroendocrine neoplasm with high serum calcitonin level, a case report, with literature review.
Motiee-Langroudi M; Farahzadi A; Ansari R; Saffar H; Darabi R; Abbasi M
Clin Case Rep; 2022 Dec; 10(12):e6751. PubMed ID: 36578797
[TBL] [Abstract][Full Text] [Related]
3. A calcitonin-producing neuroendocrine tumor of the larynx: a case report.
Insabato L; De Rosa G; Terracciano LM; Lupoli G; Montedoro D; Ravetto C
Tumori; 1993 Jun; 79(3):227-30. PubMed ID: 8236510
[TBL] [Abstract][Full Text] [Related]
4. Management of thyroid cancer: United Kingdom National Multidisciplinary Guidelines.
Mitchell AL; Gandhi A; Scott-Coombes D; Perros P
J Laryngol Otol; 2016 May; 130(S2):S150-S160. PubMed ID: 27841128
[TBL] [Abstract][Full Text] [Related]
5. [Neuroendocrine carcinoma of the larynx with secretion of calcitonin: primary tumor or metastasis of the medullary thyroid carcinoma?].
Vildé F; Arkwright S; Paoli C; Périchon I; Le Charpentier Y; Le Bodic MF
Ann Pathol; 1996; 16(2):104-7. PubMed ID: 8767676
[TBL] [Abstract][Full Text] [Related]
6. Case Report: Unmasking Hypercalcemia in Patients With Neuroendocrine Neoplasms. Experience From Six Italian Referral Centers.
Giannetta E; Sesti F; Modica R; Grossrubatscher EM; Guarnotta V; Ragni A; Zanata I; Colao A; Faggiano A
Front Endocrinol (Lausanne); 2021; 12():665698. PubMed ID: 34093441
[TBL] [Abstract][Full Text] [Related]
7. Calcitonin-Secreting Neuroendocrine Carcinoma of Larynx with Metastasis to Thyroid.
LaBryer L; Sawh R; McLaurin C; Scofield RH
Case Rep Endocrinol; 2015; 2015():606389. PubMed ID: 26491576
[TBL] [Abstract][Full Text] [Related]
8. Intraoperative high-dose calcium stimulation test in patients with sporadic medullary thyroid carcinoma is highly accurate in predicting lateral neck metastases.
De Crea C; Raffaelli M; Milano V; Carrozza C; Zuppi C; Bellantone R; Lombardi CP
Surgery; 2016 Jan; 159(1):70-6. PubMed ID: 26456123
[TBL] [Abstract][Full Text] [Related]
9. The role of PET-CT scan with somatostatin analogue labelled with gallium-68 (⁶⁸Ga-DOTA-TATE PET-CT) in diagnosing patients with disseminated medullary thyroid carcinoma (MTC).
Pałyga I; Kowalska A; Gąsior-Perczak D; Tarnawska-Pierścińska M; Słuszniak J; Sygut J; Góźdź S
Endokrynol Pol; 2010; 61(5):507-11. PubMed ID: 21049467
[TBL] [Abstract][Full Text] [Related]
10. Positron emission tomography (18FDG-PET) in the detection of medullary thyroid carcinoma metastases.
Mucha SA; Kunert-Radek J; Pomorski L
Endokrynol Pol; 2006; 57(4):452-5. PubMed ID: 17006852
[TBL] [Abstract][Full Text] [Related]
11. High CEA levels in a case of resected colorectal cancer: delayed diagnosis of metachronous medullary thyroid cancer.
Chen SW; Chen YK
World J Surg Oncol; 2017 Dec; 15(1):230. PubMed ID: 29284496
[TBL] [Abstract][Full Text] [Related]
12. Medullary thyroid cancer with undetectable serum calcitonin.
Brutsaert EF; Gersten AJ; Tassler AB; Surks MI
J Clin Endocrinol Metab; 2015 Feb; 100(2):337-41. PubMed ID: 25490273
[TBL] [Abstract][Full Text] [Related]
13. Calcitonin-negative neuroendocrine tumor of the thyroid: a distinct clinical entity.
Chernyavsky VS; Farghani S; Davidov T; Ma L; Barnard N; Amorosa LF; Trooskin SZ
Thyroid; 2011 Feb; 21(2):193-6. PubMed ID: 21275766
[TBL] [Abstract][Full Text] [Related]
14. Thyroid transcription factor-1, but not p53, is helpful in distinguishing moderately differentiated neuroendocrine carcinoma of the larynx from medullary carcinoma of the thyroid.
Hirsch MS; Faquin WC; Krane JF
Mod Pathol; 2004 Jun; 17(6):631-6. PubMed ID: 15098009
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of sporadic medullary thyroid carcinoma: the importance of routine measurement of serum calcitonin in the diagnostic evaluation of thyroid nodules.
Rieu M; Lame MC; Richard A; Lissak B; Sambort B; Vuong-Ngoc P; Berrod JL; Fombeur JP
Clin Endocrinol (Oxf); 1995 May; 42(5):453-60. PubMed ID: 7621562
[TBL] [Abstract][Full Text] [Related]
16. Surgical strategy for the treatment of sporadic medullary thyroid carcinoma: our experience.
Lupone G; Antonino A; Rosato A; Zenone P; Iervolino EM; Grillo M; De Palma M
G Chir; 2012; 33(11-12):395-9. PubMed ID: 23140924
[TBL] [Abstract][Full Text] [Related]
17. Calcitonin-secreting neuroendocrine tumor of the larynx, a diagnostic challenge of a rare neoplasm: a case report and literature review.
Filippini DM; Abeshi A; Tober N; Marchese PV; Andrini E; Lamberti G; Agosti R; Molinari G; Fermi M; Presutti L
AME Case Rep; 2024; 8():21. PubMed ID: 38234336
[TBL] [Abstract][Full Text] [Related]
18. Impact of ¹⁸F-FDG PET/CT for detecting recurrence of medullary thyroid carcinoma.
Ozkan E; Soydal C; Kucuk ON; Ibis E; Erbay G
Nucl Med Commun; 2011 Dec; 32(12):1162-8. PubMed ID: 21946617
[TBL] [Abstract][Full Text] [Related]
19. Neuroendocrine Neoplasms of the Larynx: A Clinicopathologic Analysis of 27 Neuroendocrine Tumors and Neuroendocrine Carcinomas.
Bal M; Sharma A; Rane SU; Mittal N; Chaukar D; Prabhash K; Patil A
Head Neck Pathol; 2022 Jun; 16(2):375-387. PubMed ID: 34401980
[TBL] [Abstract][Full Text] [Related]
20. Extrathyroidal Calcitonin Secreting Tumors: Pancreatic Neuroendocrine Tumors in Patients With Multinodular Goiter: Two Case Reports.
Giannetta E; Gianfrilli D; Pozza C; Lauretta R; Graziadio C; Sbardella E; Baroli A; Caronna R; Chirletti P; Lenzi A; Isidori AM
Medicine (Baltimore); 2016 Jan; 95(3):e2419. PubMed ID: 26817871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]